版本:
中国

BRIEF-Intelgenx secures a license for tadalafil erectile dysfunction dosing patent

Nov 21 Intelgenx Technologies Corp :

* Intelgenx Technologies - announced signing of binding term sheet for license to Eli Lilly and co's tadalafil dosing patent, U.S. patent no. 6,943,166

* Press release - Intelgenx secures a license for tadalafil erectile dysfunction dosing patent Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐